Risk adjusted premium subsidies and risk sharing: Key elements of the competitive sickness fund market in the Netherlands

Health Policy

Volumn 65, Issue 1, 2003, Pages 49-62

  Lamers, Leida M ^a   Van Vliet, René C J A ^a   Van De Ven, Wynand P M M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Consumer mobility; Risk adjusted premium subsidies; Risk selection; Risk sharing; Sickness fund

Indexed keywords

CONSUMER; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH STATUS; NETHERLANDS; PATIENT RIGHT; PRIVATE HEALTH INSURANCE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SALARY;

EID: 0038121719     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(02)00116-1     Document Type: Article

References (14)

1. Enthoven A.C. Consumer-choice health plan; a national-health-insurance proposal based on regulated competition in the private sector. New England Journal of Medicine. 298:1978;709-720.
2. Elsinga E. Political decision-making in health care: the Dutch case. Health Policy. 11:1989;243-255.
3. Sickness Fund Council. Onderzoek 'effecten aanvullende verzekering' (Study 'Effects of supplementary insurance'). Sickness Fund Council, Amstelveen, 1999.
4. Van de Ven WPMM, Ellis RP. Risk adjustment in competitive health plan markets. Chapter 14. In: Culyer AJ, Newhouse JP, editors. Handbook of Health Economics. Amsterdam: Elsevier Science, 2000: 755-845.
5. SER-advies. Naar een gezond stelsel van ziektekostenverzekeringen (Towards a healthy system of health care insurance). Publicatienummer 12, SER, 2000.
6. Van de Ven W.P.M.M., van Vliet R.C.J.A. How can we prevent cream skimming in a competitive health insurance market? The great challenge for the 90s. Zweifel P., Frech H.E. Health Economics Worldwide. 1992;23-46 Kluwer, Dordrecht.
7. Oudshoorn M. Stemmen met de voeten: op welke grond? Een onderzoek naar motieven van ziekenfondsverzekerden voor het veranderen van ziekenfonds (Changing sickness funds: A study of the motives of sickness fund enrolees to change sickness funds). Afstudeerscriptie, Erasmus Universiteit Rotterdam, 2000.
8. Buchmueller TC, Feldstein PJ. The effect of price on switching among health plans. Journal of Health Economics, 1997:231-247.
9. Gibbs D.A., Sangl J.A., Burris B. Consumer perspectives on information needs for health plan choice. Health Care Financing Review. 18:1996;55-73.
10. Tumlinson A., Bottigheimer H., Mahoney P., Stone E.M., Hendricks A. Choosing a health plan: what information will consumers use? Health Affairs. 16:1997;229-238.
11. Schut F.T. Prijsconcurrentie ziekenfondsen nog niet effectief (Price competition between sickness funds not effective yet). Economisch Statistische Berichten. 86:2001;172-175.
12. Lamers L.M. Pharmacy Costs Groups: a risk-adjuster for capitation payments based on the use of prescribed drugs. Medical Care. 37:1999;824-830.
13. Ash A., Porell F., Gruenberg L., et al. Adjusting Medicare capitation payments using prior hospitalization data. Health Care Financing Review. 10:1989;17-29.
14. Lamers L.M. Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation. Health Policy. 45:1998;15-32.